Dr Reddy's Labs launches copy of BI drug; move may lead to legal battle

Dr Reddy's Labs launches copy of BI drug; move may lead to legal battle Under its brand Vicra, Dr. Reddy's is expected to sell the drug in India at less than a third of the price charged by Boehringer Ingelheim. According to sources the 10 mg variant of Dr. Reddy's brand may cost ₹15 per tablet against ₹51 of the innovator's brand. https://ift.tt/eA8V8J